Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

The authors suggest that a new type of hair loss exists, which is different from alopecia areata.

Men can experience female pattern hair loss, needing different treatments.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Female pattern hair loss is common, often starts in the 30s or 40s, worsens after menopause, and can negatively affect quality of life.

Early diagnosis and personalized treatment are crucial for managing Female Pattern Hair Loss in women.

Postmenopausal women often experience hair loss on the scalp and increased facial hair, but iron supplements may not help.

Stress can cause temporary hair loss, which usually gets better after the stress is gone.

Men's and women's pattern hair loss progress differently, with men showing more hair thinning and women having more widespread hair loss.

These hair loss conditions might be part of a spectrum, not separate issues.

Scalp biopsy and digital phototrichogram help diagnose and manage different types of diffuse hair loss.

Fibrosing alopecia in a pattern distribution is a type of hair loss that may often be overlooked, especially in men.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Androgenetic alopecia causes hair thinning in women, affecting their quality of life.

Most older adults experience pattern hair loss due to shrinking hair follicles, with men and women showing different balding patterns.

Female pattern hair loss causes thinning hair on top of the scalp, treatable with limited success.

Many women's hair loss is due to health issues, medication, nutrition, or stress.

Long-term use of finasteride can help treat hair loss.

The conclusion is that detailed clinical descriptions help pathologists diagnose hair loss conditions more accurately.

Scalp edema may be a new variant of conditions reacting to scarring alopecia like LPP.

Adolescents with hair loss show different hormone levels by sex and often have related metabolic issues.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

AGA more common in men, Koreans have lower rates and unique patterns.

Women with thinning hair have thinner hair strands than women without hair loss.

A new variant of lichen planopilaris causing diffuse hair thinning was identified.